iBio Declines: Bulls Don’t Mind
iBio Inc (NASDAQ: IBIO)
iBio had an incredible day in the market yesterday after announcing that it had received a notice from the US patent office letting them know that their patent application has been approved and their patent will become active effective August 26th. However, today the story has been quite a bit different. Currently (1:29), IBIO is trading at $0.81 per share after a loss of 0.75% so far today. However, the bulls on the stock aren’t concerned in the least. The reality is that what we’re seeing from the stock today is nothing more than normal market activity. following overwhelmingly positive news, we tend to see overreactions in the market. Those overreactions are then corrected the next day before gains ensue. With that said, we can expect to see more gains out of this one shortly; so make sure to watch it closely. 0.810.01 (0.75%)
MannKind Corporation Continues Strong Activity After Several Pieces Of Positive News
MannKind Corporation (NASDAQ: MNKD)
MannKind Corporation is having yet another strong day in the market as the stock continues to break ties with the bulls. Over the past several months, MNKD just hasn’t seen the positive activity that many believe it deserves. However, that’s all starting to change. On Monday, MNKD reported earnings that were better than analyst expectations. Beyond earnings, the company also appointed a new CMO that has incredible experience in the industry and announced during their earnings call that they are nearing regulatory approval for Afrezza in Europe. All of this news has caused upward activity in the stock since; and that activity continues today. Currently (1:32), MNKD is trading at $4.37 per share after a gain of 4.97% so far today. Considering the reason behind the growth, I’m not expecting it to end anytime soon. So, keep your eyes on this one for the opportunities that are to come.
Novavax Stock Falls: Bulls Don’t Mind
Novavax, Inc. (NASDAQ: NVAX)